Prescription Drug Prices Need Reform

Prescription drug prices continue to rise year after year, leaving far too many Americans struggling to afford the medications they rely on. No one should have to choose between paying for groceries and filling a prescription; yet, that is the reality for many seniors, working families, and people living with chronic illnesses. Congress must do more to hold pharmaceutical companies accountable for excessive drug pricing practices that place profits ahead of patients.

While Americans pay some of the highest prescription drug prices in the world, pharmaceutical companies continue spending billions on television advertising and marketing campaigns. Those resources should instead be directed toward innovation, research, and lowering costs for patients. Greater transparency is also needed so Americans can better understand why the same medications often cost far more here than they do in other countries.

There is broad public support for reform. A recent survey found that 96% of voters support action to lower prescription drug prices in the United States. That level of agreement is rare and shows just how frustrated Americans have become with the current system.

One policy that deserves serious consideration is the Most Favored Nation model, which would help ensure Americans do not pay more for prescription drugs than patients in other developed countries. Policies like this could provide meaningful relief for families who are already stretched thin by rising healthcare costs.

Affordable healthcare should not be a privilege reserved only for those who can keep up with rising prices. Congress should listen to the overwhelming majority of Americans calling for reform and take meaningful action to lower prescription drug costs.

Authored by Colin Mackenzie, Minneapolis.